Shell today announced that it will go ahead with the first carbon capture and storage (CCS) project for an oil sands operation in Canada. The Quest project will be built on behalf of the Athabasca Oil Sands Project joint venture owners (Shell, Chevron and Marathon Oil) and with support from the Governments of Canada and Alberta.
CCS is critical to meeting the huge projected increase in global energy demand while reducing carbon dioxide (CO2) emissions, explained Peter Voser, Chief Executive Officer of Royal Dutch Shell plc. “If you want to achieve climate change goals, CCS has to be part of the solution. We are helping to advance CCS technology on a number of fronts around the world, but Quest will be our flagship project.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shell-first-oil-sands-css-project/56586/
Some of us process sensory input more effectively through visual means, others through auditory stimuli, and others through a kinesthetic (a touch or feel) approach. Here\\\'s a very simple way to begin to contemplate which way your genius accesses information. Imagine for a moment that you are buying a new item of clothing for an important meeting. Would you be most influenced to buy primarily for a) the color and style of the outfit; b) the benefits the salesperson tells you about the clothing; c) the texture and feel of the fabric. If you chose \\\
CHS Inc., the nation’s leading cooperative and a global energy, grains and foods company, is committed to continued growth that will drive economic value to its farmer owners and the rural communities in which they live, its leaders told attendees at its recent annual meeting.
“Our ultimate responsibility is to invent the CHS of the future by making the decisions, executing the investments and managing the financial health of this company in a manner that not only adds value for you today, but continues to pay off 10 and 20 years down the road,” CHS President and Chief Executive Officer Carl Casale told attendees. “Ultimately, it’s about taking actions today that will benefit tomorrow’s owner, the generations that are now playing in farm yards or buying their first blue FFA jackets.”
To view the Multimedia News Release, go to http://www.multivu.com/mnr/58034-chs-inc-putting-future-first-for-cooperative-farmer-owners
Two all-electric vehicles fall short of meeting the Insurance Institute for Highway Safety’s awards criteria, but consumers who want to minimize gas consumption while also prioritizing safety can choose from two plug-in hybrids that earn the 2017 TOP SAFETY PICK+ award.
The two recently evaluated all-electric models are the 2017 Tesla Model S and the 2017 BMW i3. The plug-in hybrid models are the Chevrolet Volt, whose award was announced in December, and the Toyota Prius Prime.
To qualify for the 2017 TOP SAFETY PICK award, a vehicle must earn good ratings in all five crashworthiness evaluations — small overlap front, moderate overlap front, side, roof strength and head restraints — and come with a front crash prevention system that earns an advanced or superior rating. The “plus” is awarded to vehicles that meet all those criteria and also come with good or acceptable headlights.
Asuragen Inc., a leading molecular diagnostics company, today announced results from a study demonstrating that a new molecular test called Xpansion Interpreter® can improve the determination of a woman’s risk of having a child with fragile X syndrome, the most common inherited cause of intellectual disability and autism, compared to existing risk measures. The Xpansion Interpreter Test is based on a technology breakthrough that reveals both the number and position of “interrupting” DNA sequences in the fragile X gene of the mother and more accurately estimates the likelihood that her child will have fragile X syndrome. The study will be published in the April issue of the American Journal of Medical Genetics and presented today at the 2013 American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting in Phoenix, AZ.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60719-asuragen-xpansion-interpreter-xi-test-data-fragile-x-syndrome-autism
Moms have been after their kids for years. Doctors, nutritionists, the government and gurus hound us but still, most Americans don’t eat enough vegetables. A recent Centers for Disease Control study shows no U.S. state is meeting the objectives for vegetable consumption. Now, Green Giant™ is introducing a simple solution: NEW Green Giant™ Veggie Blend-Ins™ 100% Carrot Purée, 100% Spinach Purée and 100% Butternut Squash Purée.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65725-general-mills-green-giant-veggie-blend-ins-jessica-seinfeld-vegout-purees
Extending its award-winning “Learn the Signs” campaign, Autism Speaks – the world’s leading autism science and advocacy organization – today joined the Ad Council, along with partner agencies BBDO New York and LatinWorks, to announce the launch of a new series of public service advertisements (PSAs) designed to reach African American and Hispanic parents. According to research, children in these communities are often diagnosed later than the average. The PSAs, which are being distributed to media outlets nationwide this week, show some of the early signs of autism and encourage parents to take immediate action if their child is not meeting standard developmental milestones.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61698-ad-council-and-autism-speaks-launch-psa-campaign
From the showroom floor of its National Dealer Meeting in Memphis, Tenn., Kubota Tractor Corporation announced the introduction of its all-new RTV X-Series, the next generation lineup of work utility vehicles re-engineered and Kubota-built from the ground up. With a superior ride and unmatched terrainability, Kubota’s new RTV X-Series delivers a whole new level of exceptional styling, operator comfort, durability and workhorse capability.
To view Multimedia News Release, go to http://www.multivu.com/mnr/63762-kubota-debuts-all-new-rtv-x-series-diesel-utility-vehicle
Reproductive Medicine Associates of New Jersey (http://www.rmanj.com) today presented interim findings from its BEST (Blastocyst Euploid Selective Transfer) trial, the first well-controlled clinical trial comparing in vitro fertilization (IVF) pregnancy rates in a group of women receiving a single embryo transfer (SET) with comprehensive chromosome screening (CCS) with a group receiving traditional morphology-based double embryo transfer (DET). The findings were presented at the American Society for Reproductive Medicine 68th Annual Meeting in San Diego, October 20-24, 2012.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58883-rmanj-best-trial-results-ivf-pregnancy-rates-women-asrm-annual-meeting
Diabetes experts met and determined that some self-monitoring blood glucose (SMBG) systems, despite meeting accuracy standards at the time of U.S. Food and Drug Administration (FDA) clearance, fail to consistently meet accuracy standards once on the market, potentially putting patient health at risk. In a public meeting convened by the Diabetes Technology Society on May 21, 2013, in Arlington, Virginia, leading academic clinicians, clinical chemists, medical device experts, patient advocates and FDA representatives reviewed a growing body of peer-reviewed research demonstrating that the performance of some blood glucose monitors on the market may not be meeting accuracy standards.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61870-diabetes-technology-society-inaccurate-blood-glucose-monitors-risky
